{"id":53193,"date":"2021-03-03T15:58:01","date_gmt":"2021-03-03T13:58:01","guid":{"rendered":"http:\/\/infois.ro\/?p=53193"},"modified":"2021-03-03T15:58:01","modified_gmt":"2021-03-03T13:58:01","slug":"antibiotice-si-a-triplat-vanzarile-de-medicamente-in-europa-in-2020","status":"publish","type":"post","link":"https:\/\/infois.ro\/?p=53193","title":{"rendered":"Antibiotice \u0219i-a triplat v\u00e2nz\u0103rile de medicamente \u00een Europa, \u00een 2020"},"content":{"rendered":"

\"\"<\/a><\/p>\n

Calitatea produselor Antibiotice Ia\u0219i a impulsionat cre\u0219terea cererii de medicamente, marca Antibiotice, pe pie\u021bele externe, \u00een anul pandemic 2020, \u00een special \u00een statele europene. Astfel, la finalul anului trecut, valoarea produselor exportate \u00een \u021b\u0103ri europene, puternic reglementate \u0219i greu accesibile, s-a triplat, determin\u00e2nd cre\u0219terea ponderii exporturilor la peste 46% din cifra de afaceri.<\/strong><\/p>\n

\u00a0<\/strong><\/p>\n

\u00cen anul 2020, \u00een contextul unui an atipic, cu toate provoc\u0103rile determinate de pandemia cu virusul SARS-CoV-2, Antibiotice Ia\u0219i a \u00eenregistrat\u00a0 o dinamic\u0103 important\u0103 a v\u00e2nz\u0103rilor \u00een Europa, prin triplarea exporturilor c\u0103tre pie\u021bele reprezentate de: Danemarca, Marea Britanie, Olanda, Lituania, Letonia, Ungaria.<\/p>\n

Aceste pie\u021be sunt dificil de accesat ca urmare a standardelor de calitate ridicate impuse de sistemele de s\u0103n\u0103tate, precum \u0219i a concuren\u021bei cu cei mai importan\u021bi produc\u0103tori farmaceutici din lume.<\/p>\n

\n

\u00cen plus, m\u0103surile de restric\u021bionare a v\u00e2nz\u0103rilor c\u0103tre pia\u021ba extern\u0103 (impuse \u00een starea de urgen\u021b\u0103 \u0219i de alert\u0103), perturbarea transportului terestru \u0219i aerian c\u0103tre toate zonele lumii \u0219i documenta\u021bia suplimentar\u0103 necesar\u0103 pentru aprobarea exporturilor, au solicitat identificarea de solu\u021bii rapide \u0219i eficiente.<\/p>\n

\n

Adapt\u00e2ndu-se contextului \u0219i noilor condi\u021bii, \u00een anul 2020, Antibiotice Ia\u0219i a reu\u0219it s\u0103 c\u00e2\u0219tige mai multe licita\u021bii la nivel interna\u021bional precum cele din Statele Unite ale Americii, Marea Britanie, Ungaria \u0219i Lituania pentru medicamente incluse \u00een tratamentul asociativ al infec\u021biilor complicate determinate de virusul SARS-CoV-2.<\/p>\n

\n

Fiind identificat\u0103 ca un important\u00a0 produc\u0103tor de medicamente antiinfec\u021bioase sterile injectabile, compania a reu\u0219it performan\u021ba c\u00e2\u0219tig\u0103rii licita\u021biei organizate de Comisia European\u0103 pentru Amoxicilina\/Clavulanat injectabil, un medicament antiinfec\u021bios esen\u021bial din lista OMS (Organiza\u021bia Mondial\u0103 a S\u0103n\u0103t\u0103\u021bii) pentru tratamentul pacien\u021bilor Covid-19.<\/p>\n

\n

Topul v\u00e2nz\u0103rilor este condus de produsele AmpiPlus, AmoxiPlus, Nafcilina, Oxacilina, medicamente antiinfec\u021bioase injectabile. Al\u0103turi de medicamentele antiinfec\u021bioase, reprezentative pentru brandul companiei, Antibiotice a livrat \u00een Europa medicamente destinate terapiei cardiovasculare \u0219i suplimente alimentare ce fac parte dintr-o direc\u021bie recent\u0103 de dezvoltare a portofoliului de produse.<\/p>\n

\n

\u00cen acest context, v\u00e2nz\u0103rile de produse finite \u00een anul 2020, \u00een teritoriile ATB din Europa, America, Asia de Sud Est au ajuns la 90 de milioane lei, \u00eenregistr\u00e2nd o cre\u0219tere de 8% fa\u021b\u0103 de anul 2019.<\/p>\n

\n

La aceste exporturi, se adaug\u0103 v\u00e2nz\u0103rile externe de substan\u021b\u0103 activ\u0103 Nistatin\u0103, pentru care Antibiotice este lider mondial \u0219i care au ridicat valoarea total\u0103 afacerilor dezvoltate de Antibiotice pe pia\u021ba interna\u021bional\u0103 la 158 mil. lei, \u00een cre\u0219tere cu 4% fa\u021b\u0103 de anul anterior.<\/p>\n

\n

Cre\u0219terea notoriet\u0103\u021bii brandului Antibiotice, dezvoltarea unor branduri de produse, expansiunea pe noi pie\u021be interna\u021bionale \u0219i consolidarea parteneriatelor existente r\u0103m\u00e2n prioritare \u0219i \u00een 2021, reprezent\u00e2nd piloni de dezvoltare ai companiei pentru perioada 2021- 2030.<\/p>\n

\u00a0<\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"

Calitatea produselor Antibiotice Ia\u0219i a impulsionat cre\u0219terea cererii de medicamente, marca Antibiotice, pe pie\u021bele externe,… more »<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":24269,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[6,41],"tags":[74,279,635,40,3123,13132,5465],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/infois.ro\/index.php?rest_route=\/wp\/v2\/posts\/53193"}],"collection":[{"href":"https:\/\/infois.ro\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/infois.ro\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/infois.ro\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/infois.ro\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=53193"}],"version-history":[{"count":1,"href":"https:\/\/infois.ro\/index.php?rest_route=\/wp\/v2\/posts\/53193\/revisions"}],"predecessor-version":[{"id":53194,"href":"https:\/\/infois.ro\/index.php?rest_route=\/wp\/v2\/posts\/53193\/revisions\/53194"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/infois.ro\/index.php?rest_route=\/wp\/v2\/media\/24269"}],"wp:attachment":[{"href":"https:\/\/infois.ro\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=53193"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/infois.ro\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=53193"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/infois.ro\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=53193"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}